ACC

Analysis Details SGLT2 Inhibitors Benefit Across Heart Failure Subgroups

May 20, 2021

Hear from Deepak Bhatt, MD, MPH, on a systematic review and meta-analysis of SGLT2 inhibitor trials examining the effects of the class on heart failure across multiple subgroups, including those with preserved ejection fraction.

ACC.21 Top Data Summary

May 19, 2021

Our editorial staff and advisory board have teamed up to provide you with a shortlist of highlighted data and summary slides on their picks for the most important data to be released at the American College of Cardiology's 70th Annual Scientific Session.

Dissonance Between Clinicians and Patients Could Prevent Optimal Prescription of Oral Anticoagulants

May 19, 2021

An analysis of patient and clinician responses to surveys within BOAT-AF suggests many were willing to consider DOACs but were never prescribed anticoagulation and also provides insight into how trends in this cohort compared to those in the ACC's PINNACLE registry.

ACC.21 Simulation Study Estimates CV Event Risk Reduction with Bempedoic Acid

May 19, 2021

A pooled risk simulation of phase 3 data of bempedoic acid suggests the first-in-class ATP citrate lyase inhibitor could reduce risk of cardiovascular events in patients with established cardiovascular disease and elevated LDL-C.

RADIANCE-HTN TRIO Supports Use of Renal Denervation in Refractory Hypertension

May 18, 2021

Results of RADIANCE-HTN TRIO suggest ultrasound renal denervation could improve blood pressure control in patients with refractory hypertension, suggesting RDN was associated with a mean reduction of 8 mmHg from baseline a 4.5 mmHg improvement over sham procedure.

COVID-19 Has Increased Burnout, Desire for Career Change in Cardiology

May 17, 2021

Results of a well-being study presented at ACC.21 paint a grim picture related to the impact of COVID-19 on burnout and well-being among cardiology professionals. We sat down with lead investigator Laxmi Mehta, MD, for further perspective on the issue.